Objective. Systemic sclerosis (SSc) is a connective tissue disorder characterized by fibrosis of the skin and internal organs. Although the esophagus is the most frequently affected part of the gastrointestinal tract, all other segments can be involved. The present study was undertaken to evaluate the fibrotic process and the expression of fibrogenic cytokines in the gastric wall of SSc patients with gastroesophageal involvement. Methods. Full-thickness surgical and endoscopic gastric biopsy samples were obtained from 14 SSc patients and 10 controls. Tissue sections were either stained with Masson's trichrome or by immunohistochemistry and analyzed for the expression of types I, III, and IV collagen, α-smooth muscle actin (α-SMA), transforming growth factor β (TGFβ), connective tissue growth factor (CTGF), and endothelin 1 (ET-1). Results. In the gastric wall of SSc patients, Masson's trichrome staining and immunohistochemistry for types I and III collagen revealed a high amount of collagen in the lamina propria that increased toward the muscularis mucosae. In addition, muscle layers showed features of atrophy, with wide areas of focal fibrosis surrounding smooth muscle cells. Type IV collagen was present around glands and small vessels, suggesting a thickening of the basal lamina. The expression of the fibrogenic cytokines TGFβ and CTGF, ET-1, and the myofibroblast marker α-SMA was stronger in SSc patients than in controls. Conclusion. A pronounced deposition of collagen, the presence of myofibroblasts, and increased expression of several profibrotic factors are important hallmarks in the stomach of patients with SSc. The fibrotic involvement of the gastric wall may account for muscle atrophy leading to stomach hypomotility in SSc. © 2007, American College of Rheumatology.

Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients / Manetti, Mirko; Neumann, E.; Milia, A. F.; Tarner, I. H.; Bechi, P.; Matucci Cerinic, M.; Ibba, Lidia; Müller Ladner, U.. - In: ARTHRITIS AND RHEUMATISM. - ISSN 1529-0131. - STAMPA. - 56:(2007), pp. 3442-3447. [10.1002/art.22940]

Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients

MANETTI, MIRKO;Matucci Cerinic M.;IBBA, LIDIA;
2007

Abstract

Objective. Systemic sclerosis (SSc) is a connective tissue disorder characterized by fibrosis of the skin and internal organs. Although the esophagus is the most frequently affected part of the gastrointestinal tract, all other segments can be involved. The present study was undertaken to evaluate the fibrotic process and the expression of fibrogenic cytokines in the gastric wall of SSc patients with gastroesophageal involvement. Methods. Full-thickness surgical and endoscopic gastric biopsy samples were obtained from 14 SSc patients and 10 controls. Tissue sections were either stained with Masson's trichrome or by immunohistochemistry and analyzed for the expression of types I, III, and IV collagen, α-smooth muscle actin (α-SMA), transforming growth factor β (TGFβ), connective tissue growth factor (CTGF), and endothelin 1 (ET-1). Results. In the gastric wall of SSc patients, Masson's trichrome staining and immunohistochemistry for types I and III collagen revealed a high amount of collagen in the lamina propria that increased toward the muscularis mucosae. In addition, muscle layers showed features of atrophy, with wide areas of focal fibrosis surrounding smooth muscle cells. Type IV collagen was present around glands and small vessels, suggesting a thickening of the basal lamina. The expression of the fibrogenic cytokines TGFβ and CTGF, ET-1, and the myofibroblast marker α-SMA was stronger in SSc patients than in controls. Conclusion. A pronounced deposition of collagen, the presence of myofibroblasts, and increased expression of several profibrotic factors are important hallmarks in the stomach of patients with SSc. The fibrotic involvement of the gastric wall may account for muscle atrophy leading to stomach hypomotility in SSc. © 2007, American College of Rheumatology.
2007
56
3442
3447
Goal 3: Good health and well-being for people
Manetti, Mirko; Neumann, E.; Milia, A. F.; Tarner, I. H.; Bechi, P.; Matucci Cerinic, M.; Ibba, Lidia; Müller Ladner, U.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/778612
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 72
  • ???jsp.display-item.citation.isi??? 70
social impact